ArticleCommunications biology2024

ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer.

Rebecca Garnham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.